StockData
Mustang Bio, Inc. logo

Mustang Bio, Inc. (MBIO) stock

MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.38−0.01 (-2.56%)

Close on Nov 18, 2026Market cap $2.88MP/E –Yield –

Mustang Bio operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Mustang Bio's operating cash flow for the twelve months ending Jun 30, 2026 was -$4.51M. For fiscal 2025 it was -$5.26M. The highest annual figure on record is -$4.13M in fiscal 2016.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.26M–
FY2024Dec 31, 2024-$11.41M–
FY2023Dec 31, 2023-$49.48M–
FY2022Dec 31, 2022-$65.07M–
FY2021Dec 31, 2021-$53.67M–
FY2020Dec 31, 2020-$37.32M–
FY2019Dec 31, 2019-$33.58M–
FY2018Dec 31, 2018-$19.24M–
FY2017Dec 31, 2017-$12.95M–
FY2016Dec 31, 2016-$4.13M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$967.00K–
Q1 FY2026Mar 31, 2026-$1.01M–
Q4 FY2025Dec 31, 2025-$1.72M–
Q3 FY2025Sep 30, 2025-$818.00K–
Q2 FY2025Jun 30, 2025-$1.34M–
Q1 FY2025Mar 31, 2025-$1.39M–
Q4 FY2024Dec 31, 2024-$2.00M–
Q3 FY2024Sep 30, 2024-$1.76M–
Q2 FY2024Jun 30, 2024-$2.34M–
Q1 FY2024Mar 31, 2024-$5.32M–
Q4 FY2023Dec 31, 2023-$7.25M–
Q3 FY2023Sep 30, 2023-$12.02M–
Q2 FY2023Jun 30, 2023-$12.39M–
Q1 FY2023Mar 31, 2023-$17.81M–
Q4 FY2022Dec 31, 2022-$15.29M–
Q3 FY2022Sep 30, 2022-$15.91M–
Q2 FY2022Jun 30, 2022-$17.58M–
Q1 FY2022Mar 31, 2022-$16.29M–
Q4 FY2021Dec 31, 2021-$14.70M–
Q3 FY2021Sep 30, 2021-$11.29M–
Q2 FY2021Jun 30, 2021-$12.10M–
Q1 FY2021Mar 31, 2021-$15.58M–
Q4 FY2020Dec 31, 2020-$9.48M–
Q3 FY2020Sep 30, 2020-$10.12M–
Q2 FY2020Jun 30, 2020-$7.57M–
Q1 FY2020Mar 31, 2020-$10.15M–
Q4 FY2019Dec 31, 2019-$9.49M–
Q3 FY2019Sep 30, 2019-$8.83M–
Q2 FY2019Jun 30, 2019-$8.78M–
Q1 FY2019Mar 31, 2019-$6.48M–
Q4 FY2018Dec 31, 2018-$6.52M–
Q3 FY2018Sep 30, 2018-$3.80M–
Q2 FY2018Jun 30, 2018-$3.36M–
Q1 FY2018Mar 31, 2018-$5.57M–
Q4 FY2017Dec 31, 2017-$5.17M–
Q3 FY2017Sep 30, 2017-$4.77M–
Q2 FY2017Jun 30, 2017-$974.00K–
Q1 FY2017Mar 31, 2017-$2.04M–
Q4 FY2016Dec 31, 2016-$2.26M–
Q3 FY2016Sep 30, 2016-$565.00K–

More Mustang Bio figures

See a number that looks wrong?